95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Substituted quinazoline compounds and methods of use
#2402Aurora kinase and Janus kinase inhibitors for prevention of graft versus host disease
#2403Carbazole derivative and organic light emitting element using same
#2404Beta lactams as modulators of glutamate uptake and methods for use thereof
#2405Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents
#2406Lanthionine synthetase C-like 2-based therapeutics
#2407HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#2408N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease
#2409APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#2410Indole carboxamide compounds
#2411Modulators of indoleamine 2,3-dioxygenase
#2412Anti-inflammatory agents
#2413Carboxylic acid compounds
#2414PKM2 modulators and methods for their use
#2415Compounds and their use for reducing uric acid levels
#2416Substituted 2,4-diaminopyrimidines as kinase inhibitors
#2417Amine-based compound and organic light-emitting device including the amine-based compound
#2418Compounds, compositions and methods
#2419ACTIVATORS OF AUTOPHAGIC FLUX AND PHOSPHOLIPASE D AND CLEARANCE OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES
#2420N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides
#2421N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activity
#2422N-[(pyrimidinyloxy)propanyl]benzamides
#2423N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity
#2424D-amino acid oxidase inhibitors and therapeutic uses thereof
#24253-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
#2426Substituted-indole-compounds as estrogen receptor down-regulators
#2427Physical form of a SGR modulator
#2428[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof
#2429Ion pair catalysis of tungstate and molybdate
#2430Androgen receptor modulating compounds
#2431EGFR inhibitor, preparation method and use thereof
#2432INHIBITORS OF BRUTON'S TYROSINE KINASE
#24333-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
#2434N-CYCLOALKYL-N-[(HETEROCYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES
#2435Blocking toll-like receptor 9 signaling with small molecule antagonist
#2436Therapeutic polymeric nanoparticles and methods of making and using same
#2437Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators
#2438Compositions and therapeutic methods for the treatment of complement-associated diseases
#2439Benzathine analogs
#2440Alpha-Ketoamide Inhibitors Of Cysteine Proteases
#2441Phosphonate compounds for treatment of complement mediated disorders
#2442Small molecule myristate inhibitors of BCR-ABL and methods of use
#2443Substituted pyrimidines as LRKK2 inhibitors
#2444Pyrimidinyloxy benzene derivatives as herbicides
#2445Synthetic route to anti-viral agents
#2446Indole derivatives for use in medicine
#2447Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same
#2448METHOD FOR PRODUCING NITROGEN-CONTAINING AROMATIC AMIDE, METHOD FOR PRODUCING PYRROLE-IMIDAZOLE POLYAMIDE, AND COMPOUND
#2449ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#2450Compositions and methods for treating infections
#2451Bisamide sarcomere activating compounds and uses therof
#2452Administration of aurora kinase inhibitors for anti-malarial therapy
#2453Voltage-dependent t-type calcium channel blocker
#2454Compositions for APP-selective BACE inhibition and uses therefor
#2455Modulators of ATP-binding cassette transporters
#2456Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
#24573-phosphoglycerate dehydrogenase inhibitors and uses thereof
#2458Wnt signaling pathway inhibitors for treatments of disease
#2459Indole derivatives and their use as protein kinase inhibitors
#2460Combinations for the treatment of neuroblastoma
#2461PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#2462Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#2463Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean
#2464Substituted asymmetric ureas as modulators of ghrelin receptor activity
#2465Autotaxin inhibitors
#2466Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors
#2467Benzazepine compounds, conjugates, and uses thereof
#2468Heterocycle and carbocycle derivatives having TRKA inhibitory activity
#2469Imidazolylamide derivative
#2470Fungicidal pyrazoles
#2471Heteroaryl inhibitors of PDE4
#2472Pyrrolobenzodiazepines
#2473Inhibitors of lysine specific demethylase-1
#2474Glycosidase inhibitors
#2475Compounds
#2476Toxin and method for preparing intermediate thereof
#2477Indole derivatives and uses thereof
#2478AHR inhibitors and uses thereof
#2479Potent dual BRD4-kinase inhibitors as cancer therapeutics
#2480Pyrimidines and variants thereof, and uses therefor
#2481Catalytic hydrogenation process for preparing pyrazoles
#2482N-heterocyclic carbene (NHC) based ligands and related methods
#2483Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative Diseases
#2484Ether compounds for treatment of complement mediated disorders
#2485Substituted pyrazin-2-amines as inhibitors of ATR kinase
#2486Aryl substituted pyrimidines for use in influenza virus infection
#2487Substituted 2-(het)arylimidazolylcarboxyamides as pesticides
#2488Sulfonyl amide derivatives for the treatment of abnormal cell growth
#24891,2,4-triazine-4-amine derivatives
#24906-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES
#2491Urea compound, preparation method therefor and medical use thereof
#2492Substituted imidazolylcarboxamides as pesticides
#2493NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF
#2494Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
#2495Substituted 2-oxyimidazolylcarboxamides as pesticides
#2496Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
#2497Heat shock protein binding compounds, compositions, and methods for making and using same
#2498BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF
#2499MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES
#2500Compounds for treatment of complement mediated disorders
#2501Benzamide and nicotinamide compounds and methods of using same
#2502Therapeutic compounds and methods of use thereof
#2503Tetrahydronaphthalene derivative
#2504Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
#2505Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#2506Solid forms of Selinexor and process for their preparation
#2507Small molecule agonists of neurotensin receptor 1
#2508Pyrazole derivatives and their uses thereof
#2509Process for making beta 3 agonists and intermediates
#2510Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof
#2511Cot modulators and methods of use thereof
#2512Nuclear transport modulators and uses thereof
#2513DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#2514Azepane derivatives and methods of treating hepatitis B infections
#2515Acrylanilide derivative, preparation method, and applications thereof in pharmacy
#2516Compound for organic-electric element, organic-electric element using same, and electronic device for same
#2517Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group
#25181-ARYL-3-AMINOALKOXY PYRAZOLES AS SIGMA LIGANDS ENHANCING ANALGESIC EFFECT OF OPIOIDS AND ATTENUATING THE DEPENDENCY THEREOF
#25192-cyanoisoindoline derivatives for treating cancer
#2520Nuclear transport modulators and uses thereof
#2521Organic light emitting element
#2522NRF2 Regulators
#2523Heteroaromatic compounds and their use as dopamine D1 ligands
#2524Pyrimidines as sodium channel blockers
#2525MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
#2526Methods for treating Huntington's disease
#2527Compounds and their use as inhibitors of N-myristoyl transferase
#2528Tank-binding kinase inhibitor compounds
#2529Process for the preparation of macitentan
#2530Bis-triazole compounds with anti-biofilm and anti-corrosion properties
#2531EGFR and ALK dual inhibitor
#2532Alkyl dihydroquinoline sulfonamide compounds
#2533Alkynyl dihydroquinoline sulfonamide compounds
#2534CHK1/2 inhibitors and irinotecan for use in the treatment of rhabdomyosarcoma
#2535Methods and compositions associated with the granulocyte colony-stimulating factor receptor
#2536Dimeric contrast agents
#2537Forms and compositions of an ERK inhibitor
#2538Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
#2539Substituted heterocyclyl derivatives as CDK inhibitors
#2540Arylazole compound and pest control agent
#2541Pyrrolidine derivatives
#2542Cyanopyrrolidine derivatives as inhibitors for DUBs
#2543Isobaric mass labels having n',n'-dimeihyl piperazine-2-carboxylic acid reporter moieties
#2544Inhibitors of human phosphatidylinositol 3-kinase delta
#2545Benzamide compounds and their use as herbicides
#2546Carbazole derivative and organic light emitting device using same
#2547Phenylimidazole compound
#2548Pharmaceutical compound
#2549CANNABINOID RECEPTOR MODULATORS
#2550Human plasma kallikrein inhibitors
#2551Trk inhibition
#2552PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
#2553Substituted benzamides useful as sodium channel blockers
#2554Pyridine compounds as fungicides
#2555Carbon monoxide releasing norbornenone compounds
#2556Rho kinase inhibitors
#2557AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS
#2558Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging
#2559TGF-ß inhibitors
#2560Pyrazole MAGL inhibitors
#2561Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
#2562Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
#2563Antimicrobial Compounds And Methods Of Making And Using The Same
#2564PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF
#2565Compositions, methods of use, and methods of treatment
#2566Process of making cenicriviroc and related analogs
#2567Pyrazole compounds and methods of making and using same
#2568Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors
#2569Compound, compositions, and methods
#2570Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
#2571Substituted hydroxypyrimidinones for treating bacterial infections
#2572Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
#2573Radiolabeled Tracers for Poly (ADP-RIBOSE) Polymerase-1 (PARP-1), Methods and Uses Therefor
#2574Inhibitors of lysine specific demethylase-1
#2575Pyrazolylaminobenzimidazole derivatives as JAK inhibitors
#2576Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
#2577Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
#2578Inhibitors of KRAS G12C mutant proteins
#2579Compositions, methods, and systems for the synthesis and use of imaging agents
#2580Heteroaryl compounds as BTK inhibitors and uses thereof
#2581Pro-Neurogenic Compounds
#2582PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES
#2583Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
#2584Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
#2585Benzopiperazine compositions as BET bromodomain inhibitors
#2586Nitrogen-containing aromatic heterocyclic compound
#2587ANTI-ALPHAVBETA1 INTEGRIN COMPOUNDS AND METHODS
#2588C5-anilinoquinazoline compounds and their use in treating cancer
#2589Substituted indazole compounds as RORgammaT inhibitors and uses thereof
#2590Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors
#2591KDM1A inhibitors for the treatment of disease
#2592Benzamide derivative
#2593DNA-PK INHIBITORS
#2594PYRIMIDINEDIONE COMPOUNDS
#2595Kinase inhibitors
#2596METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL
#2597IMIDAZOLINONE DERIVATIVES AS TRPM8 ANTAGONISTS
#2598Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
#2599Histone demethylase inhibitors
#2600COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES
#2601Disubstituted 1, 2, 4-triazine compound
#2602Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
#2603EBNA1 inhibitors and methods using same
#2604Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#2605Alkyne Compounds for Treatment of Complement Mediated Disorders
#2606Octahydropyrrolopyrroles their preparation and use
#2607Sodium channel blockers
#2608Herbicidal compounds
#2609ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#2610ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#2611Substituted 6a,7,8,9,10,12-hexahydrobenzo[e]pyrido[1,2-a][1,4]diazepines as anti-proliferative agents
#2612Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
#2613Modulators of indoleamine 2,3-dioxygenase
#2614BRD4-kinase inhibitors as cancer therapeutics
#2615ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#2616Inhibitors of EGFR and methods of use thereof
#2617Urea derivative or pharmacologically acceptable salt thereof
#2618FUSED IMIDAZOLE COMPOUNDS
#2619Lanthionine synthetase C-like 2-based therapeutics
#2620Nuclear transport modulators and uses thereof
#2621Substituted indazole derivatives active as kinase inhibitiors
#2622CARM1 inhibitors and uses thereof
#26233-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
#2624Dopamine D3 receptor antagonists
#26251,2-substituted cyclopentanes as orexin receptor antagonists
#2626Inhibitors of KRAS G12C mutant proteins
#2627Inhibitors of KRAS G12C mutant proteins
#2628Heterocyclic compounds useful as Pim kinase inhibitors
#2629Acylated N-(1 ,2,5-oxadiazol-3-yl)-, N-(1,3,4-oxadiazol-2-yl)-, N-(tetrazol-5-yl)- and N-(triazol-5-yl)-aryl carboxamides, and use thereof as herbicides
#2630Azole derivatives as apelin receptor agonist
#2631Compound for organic electric element, organic electric element comprising the same and electronic device thereof
#2632SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS
#2633Hepatitis B core protein allosteric modulators
#2634Hepatitis B core protein modulators
#2635Inhibitors of KRAS G12C mutant proteins
#2636Inhibitors of lysine specific demethylase-1
#26373-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
#2638CANNABINOID RECEPTOR MEDIATING COMPOUNDS
#2639Pharmaceutical compounds
#2640N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
#2641Apelin receptor (APJ) agonists and uses thereof
#2642Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
#2643Compositions and methods for inhibition of the JAK pathway
#2644Biaryl piperidine amide compounds and methods of use thereof
#2645Inhibitors of lysine specific demethylase-1
#2646Hepatitis B core protein modulators
#2647PSMA imaging agents
#2648Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
#2649HIV inhibitor compounds
#2650Hepatitis B core protein modulators
#26515-SULFANYLHISTIDINES AND THEIR DISULFIDES AND METHOD OF PREPARATION THEREOF
#2652Substituted imidazoles as melanocortin receptor agonists
#2653Substituted 1H-indole-2-carboxamide compounds as indoleamine-2,3-dioxygenase inhibitors
#2654Heterocyclic indoles for use in influenza virus infection
#2655AMINO QUINAZOLINES AS KINASE INHIBITORS
#2656Human plasma kallikrein inhibitors
#2657Benzazepine compounds, conjugates, and uses thereof
#2658N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS
#2659Pyrimidinone amide compounds as PDE2 inhibitors
#2660Compound and organic light-emitting element comprising same
#2661Heterocyclic compounds and uses thereof
#2662Histone demethylase inhibitors
#2663Method for removing dimethoxybenzyl group
#2664Amino pyrimidine derivatives
#26651-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-Yl)methoxy)ethyl)piperazin-1- Yl)ethanone salts
#2666APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#2667Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof
#2668LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
#2669Rho kinase inhibitors
#2670Metallo-beta-lactamase inhibitors
#2671Wnt signaling pathway inhibitors and therapeutic applications thereof
#2672[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof
#2673HIV replication inhibiting pyrimidines
#2674INHIBITION OF OLIG2 ACTIVITY
#2675Isoindoline derivatives for use in the treatment of a viral infection
#2676Drug-conjugates, conjugation methods, and uses thereof
#2677Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
#2678Janus kinase 1 selective inhibitor and pharmaceutical use thereof
#2679Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors
#2680Urea derivative and use therefor
#2681PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#2682Octahydrocyclopentapyrroles, their preparation and use
#2683CXCR-2 inhibitors for treating crystal arthropathy disorders
#2684COMPOUNDS FOR THE INHIBITION OF CYCLOPHILINS AND USES THEREOF
#2685DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#2686Preparation method of rociletinib
#26875-(5-(2-(3-aminopropdoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitfile (S)-lactate monohydrate
#2688Triazole compounds as T-type calcium channel blockers
#2689Heterocyclic compounds for the inhibition of PASK
#26901,4-disubstituted imidazole derivative
#2691Combinations and uses thereof
#2692Methods of synthesizing thyroid hormone analogs and polymorphs thereof
#2693Functionalized NANOLUC inhibitors
#2694Bis-heteroaryl derivatives as modulators of protein aggregation
#2695Modulators of calcium release-activated calcium channel
#2696N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
#26973-indol substituted derivatives, pharmaceutical compositions and methods for use
#2698Compounds and their use as BACE inhibitors
#2699Compounds and methods for inhibiting fascin
#2700Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties